Approved Selank 10

From Neurobiology to Clinical Investigation

Selank is a synthetic heptapeptide analog of the naturally occurring immunomodulatory peptide tuftsin. Originally developed by Russian researchers in the late 20th century, Selank was designed to combine neurological, cognitive, and immune-modulating properties in a single investigational compound.

With decades of laboratory and clinical evaluation, Selank has attracted interest as a research tool for studying anxiety regulation, mood stabilization, memory enhancement, and stress resilience. Its unique dual role — impacting both the central nervous system and the immune system — positions it as one of the most distinctive peptides in the nootropic and neuroregenerative research landscape.

Research Applications and Benefits

Laboratory and clinical studies suggest Selank may play a role in several key domains of neurobiology:

• Anxiolytic Effects (Anti-Anxiety)
  Selank has been studied as a non-sedating alternative to benzodiazepines, with evidence pointing toward reduced anxiety and stress responses without impairing cognition or motor function.

• Cognitive Support
  Research indicates Selank may enhance learning, memory retention, and mental clarity, making it of interest in nootropic studies.

• Mood and Stress Regulation
  By influencing the balance of monoamine neurotransmitters (such as serotonin and dopamine), Selank has been investigated for stabilizing mood and improving resilience under chronic stress.

• Immune Modulation
  Selank’s structural relation to tuftsin links it to immune-balancing properties, with studies suggesting it may help normalize immune responses in stress-induced or inflammatory states.

• Neuroprotective Properties
  Preclinical findings suggest Selank may protect neurons from oxidative damage and enhance overall neural plasticity.

As with all peptides made available for research purposes only, Selank is not approved for human consumption or therapeutic use.

• Stability and Handling – Provided in lyophilized form, Selank requires proper storage in a cool, dry environment until reconstitution.
• Regulatory Status – While Selank has undergone human clinical trials in Russia, it is not FDA-approved and remains investigational globally.
• Research Use Only – Selank should be used solely for controlled laboratory experiments and never marketed as a treatment, supplement, or drug.

Selank offers researchers a unique bridge between neuroscience and immunology, making it a powerful tool for investigating mechanisms of anxiety reduction, cognitive enhancement, mood regulation, and immune balance.

With a growing body of laboratory and clinical data, Selank continues to draw interest as a peptide that could reshape how we understand the relationship between stress, brain function, and overall resilience.